(Q34063826)

30 July 2017

1 reference

title

Host factors and the pathogenesis of HIV-induced disease (English)

1 reference

30 July 2017

0 references

1 reference

1

Fauci AS

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

30 July 2017

1 reference

30 July 2017

volume

384

1 reference

30 July 2017

issue

6609

1 reference

30 July 2017

page(s)

529-534

1 reference

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

30 July 2017

cites work

1 reference

7 January 2021

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

7 January 2021

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

7 January 2021

The immunopathogenesis of human immunodeficiency virus infection

1 reference

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

7 January 2021

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

7 January 2021

Toward an understanding of the correlates of protective immunity to HIV infection

1 reference

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

7 January 2021

AIDS as immune system activation. Key questions that remain.

1 reference

7 January 2021

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

1 reference

7 January 2021

Transient elevation of serum HIV antigen levels associated with intercurrent infection

1 reference

7 January 2021

Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1.

1 reference

7 January 2021

Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia

1 reference

7 January 2021

Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens

1 reference

7 January 2021

Accelerated course of human immunodeficiency virus infection after tuberculosis

1 reference

7 January 2021

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

7 January 2021

Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach

1 reference

7 January 2021

Early diagnosis of vertically acquired HIV-1 infection

1 reference

7 January 2021

1 reference

7 January 2021

Immune activation is a dominant factor in the pathogenesis of African AIDS

1 reference

7 January 2021

Elevated levels of tumor necrosis factor-alpha in Zairian neonate plasmas: implications for perinatal infection with the human immunodeficiency virus

1 reference

7 January 2021

Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1.

1 reference

7 January 2021

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

7 January 2021

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

1 reference

7 January 2021

Lymphocyte responses and cytokines

1 reference

7 January 2021

Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals

1 reference

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

7 January 2021

Biology of human TH1 and TH2 cells

1 reference

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

7 January 2021

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

7 January 2021

Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells

1 reference

7 January 2021

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

1 reference

7 January 2021

HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines

1 reference

7 January 2021

Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus

1 reference

7 January 2021

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

1 reference

7 January 2021

Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat

1 reference

7 January 2021

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

1 reference

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

7 January 2021

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

1 reference

7 January 2021

HIV suppression by interleukin-16.

1 reference

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

7 January 2021

Biologic features of HIV-1 that correlate with virulence in the host

1 reference

7 January 2021

Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

1 reference

7 January 2021

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

1 reference

7 January 2021

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

7 January 2021

Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality

1 reference

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

7 January 2021

Chemokine receptors: structure, function and role in microbial pathogenesis

1 reference

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

7 January 2021

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

7 January 2021

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

7 January 2021

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

1 reference

7 January 2021

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

1 reference

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

7 January 2021

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

7 January 2021

1 reference

7 January 2021

Chemokine receptors and HIV-1: an attractive pair?

1 reference

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

7 January 2021

Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines

1 reference

7 January 2021

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

1 reference

7 January 2021

Natural resistance to HIV?

1 reference

7 January 2021

Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes.

1 reference

7 January 2021

Chemoattractants attract HIV researchers

1 reference

7 January 2021

Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men

1 reference

7 January 2021

Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission

1 reference

7 January 2021

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

1 reference

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

7 January 2021

Chemokines and HIV replication

1 reference

7 January 2021

Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates

1 reference

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

7 January 2021

Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection

1 reference

7 January 2021

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

1 reference

7 January 2021

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

1 reference

7 January 2021

Nonhuman primate models for AIDS.

1 reference

7 January 2021

The simian immunodeficiency viruses

1 reference

7 January 2021

Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4

1 reference

7 January 2021

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

1 reference

7 January 2021

Identifiers

DOI

10.1038/384529A0

1 reference

30 July 2017

1 reference